Error: Could not add to watchlist. X

Amicus Therapeutics Inc

+ Watchlist
AM6:GR
Frankfurt
13.23
EUR
0.51
3.99%
As of 08:07:09 ET on 09/03/2015.
Open
13.17
Day Range
13.17 - 13.23
Volume
0
Previous Close
12.72
52Wk Range
3.94 - 17.27
1 Yr Return
152.05%
Open
13.17
Day Range
13.17 - 13.23
Volume
0
Previous Close
12.72
52Wk Range
3.94 - 17.27
1 Yr Return
152.05%
YTD Return
96.17%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (b EUR)
1.569
Shares Outstanding (m)
118.618
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
ADDRESS
6 Cedar Brook Drive
Cranbury, NJ 08512
United States
PHONE
1-609-662-2000
  • John F Crowley
    Chairman/CEO
  • Bradley L Campbell
    President/COO
  • William D Baird "Chip"
    Chief Financial Officer
  • Jay Barth
    Chief Medical Ofcr
  • Hung Do
    Chief Science Officer
Show More